In other words, even if NF-κB1 expression is reduced in patients with ulcerative colitis, it is unlikely that patients with ulcerative colitis will develop myocarditis after COVID-19 mRNA vaccination while being treated with immunosuppressive drugs. Here, NFKB1 is linked to myocarditis.